GME
68
-4
ABBV
48
-2
MMM
35
-5
CINF
27
-11
VRSK
54
-5
AMGN
39
-7
MSI
52
-3
HOG
26
-3
PLD
40
-5
VIX
22
7
WFC
58
-2
PNC
48
-2
DD
42
-3
EA
42
-2
EMN
40
-2
WEC
39
-2
DE
48
-2
KO
42
-2
BWA
44
-2
O
15
-11
GME
68
-4
ABBV
48
-2
MMM
35
-5
CINF
27
-11
VRSK
54
-5
AMGN
39
-7
MSI
52
-3
HOG
26
-3
PLD
40
-5
VIX
22
7
WFC
58
-2
PNC
48
-2
DD
42
-3
EA
42
-2
EMN
40
-2
WEC
39
-2
DE
48
-2
KO
42
-2
BWA
44
-2
O
15
-11
Financhill
Back

abrdn Bloomberg All Commodity Strat K-1 Free ETF Vs. Aligos Therapeutics Industry Stock Comparison

Sell
12

BCI
abrdn Bloomberg All Commodity Strat K-1 Free ETF

Last Price:
$19.57
Seasonality Move:
3.12%
Buy
62

ALGS
Aligos Therapeutics

Last Price:
$41.28
Seasonality Move:
-16.03%
Sell
12
abrdn Bloomberg All Commodity Strat K-1 Free ETF (BCI) is a Sell

Is abrdn Bloomberg All Commodity Strat K-1 Free ETF a Buy, Sell or Hold?

  • The current abrdn Bloomberg All Commodity Strat K-1 Free ETF [BCI] share price is $19.58. The Score for BCI is 12, which is 76% below its historic median score of 50, and infers higher risk than normal.
  • BCI is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
62
Aligos Therapeutics (ALGS) is a Buy

Is Aligos Therapeutics a Buy, Sell or Hold?

  • The current Aligos Therapeutics [ALGS] share price is $41.15. The Score for ALGS is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
  • ALGS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

BCI Stock Price Chart

What is abrdn Bloomberg All Commodity Strat K-1 Free ETF's stock price today?

  • The abrdn Bloomberg All Commodity Strat K-1 Free ETF share price today is $19.58
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BCI is experiencing slight buying pressure.

ALGS Stock Price Chart

What is Aligos Therapeutics's stock price today?

  • The Aligos Therapeutics share price today is $41.15
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALGS is experiencing slight selling pressure.

BCI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.14 Sell
Relative Strength Index (14 RSI): 37.24 Sell
Chaikin Money Flow: 119425 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (19.8 - 20.34) Sell
Bollinger Bands (100): (19.49 - 20.41) Sell

ALGS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 5.69 Buy
Relative Strength Index (14 RSI): 73.75 Buy
Chaikin Money Flow: -154898 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (23.72 - 37.64) Buy
Bollinger Bands (100): (6.81 - 25.85) Buy

BCI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 19.83 Sell
20-day SMA: 20.03 Sell
50-day SMA: 20.11 Sell
200-day SMA: 20.13 Sell
8-day EMA: 19.76 Sell
20-day EMA: 19.95 Sell
50-day EMA: 20.05 Sell
200-day EMA: 20.13 Sell

ALGS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 38.54 Buy
20-day SMA: 33.12 Buy
50-day SMA: 21.28 Buy
200-day SMA: 16.61 Buy
8-day EMA: 38.79 Buy
20-day EMA: 33.47 Buy
50-day EMA: 25.09 Buy
200-day EMA: 18.34 Buy

abrdn Bloomberg All Commodity Strat K-1 Free ETF Earnings Growth & BCI Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Aligos Therapeutics Earnings Growth & ALGS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $30.89 per share, and a decrease next year of $2.65 per share.

abrdn Bloomberg All Commodity Strat K-1 Free ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Aligos Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):